Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients

Objectives. To evaluate the effect of levothyroxine (LT(4)) replacement therapy on nonalcoholic fatty liver disease (NAFLD) in subclinical hypothyroidism (SCH) patients. Methods. This study was a post hoc analysis of a randomized controlled trial and involved 33 significant and 330 mild SCH patients...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J Endocrinol
Prif Awduron: Liu, Lu, Yu, Yong, Zhao, Meng, Zheng, Dongmei, Zhang, Xu, Guan, Qingbo, Xu, Chao, Gao, Ling, Zhao, Jiajun, Zhang, Haiqing
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Hindawi 2017
Pynciau:
Clinical Study
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5394912/
https://ncbi.nlm.nih.gov/pubmed/28473851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5753039
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg